At what estimated glomerular filtration rate (eGFR) should a patient be referred to a nephrologist?

Nephrology Referral Based on eGFR

Refer patients to nephrology when eGFR falls below 30 mL/min/1.73 m² (CKD stage G4-G5). This is the clear, consistent threshold across all major guidelines 1, 2, 3, 4.

Primary Referral Criterion

The eGFR <30 mL/min/1.73 m² threshold represents the point where:

• Patients require specialized management of CKD complications (anemia, bone disease, electrolyte disturbances)
• Planning for renal replacement therapy becomes necessary
• Mortality and morbidity risks substantially increase

Important caveat: If the eGFR <30 is stable, the diagnosis is clear, and the patient has very advanced age or severe comorbidities suggesting short life expectancy, formal referral may not be necessary—specialist advice alone may suffice 1.

Additional Referral Triggers (Regardless of eGFR)

Beyond the eGFR threshold, refer immediately for:

• Significant albuminuria: ACR ≥300 mg/g (≥30 mg/mmol) or PCR ≥500 mg/g (≥50 mg/mmol) 1, 2

  • The Canadian guidelines suggest a higher threshold of ACR ≥60 mg/mmol (approximately 600 mg/g) for referral, as this level may warrant kidney biopsy and immunosuppressive therapy 1

• Rapid progression: Sustained eGFR decline >20% after excluding reversible causes 1

• Resistant hypertension: Requiring ≥4 antihypertensive agents 1, 2

• Persistent hyperkalemia 1, 2

• Unexplained hematuria: RBC >20/hpf with red cell casts 1, 2

• Hereditary kidney disease or recurrent nephrolithiasis 1, 2

Risk-Based Approach (Emerging Standard)

The most recent 2025 KDOQI guidelines introduce a risk-based criterion: refer when the 2-year kidney failure risk is ≥10% using validated prediction tools like the Kidney Failure Risk Equation (KFRE) 5. This approach:

• Incorporates both eGFR and proteinuria
• Identifies patients who truly need specialized care regardless of absolute eGFR
• May prevent unnecessary referrals of elderly patients with stable, low-risk CKD

A 5-year kidney failure risk of 3-5% can also guide referral decisions 5.

Diabetes-Specific Considerations

For patients with diabetes, the 2023 ADA guidelines recommend referral when 3:

• eGFR <30 mL/min/1.73 m²
• Continuously rising albuminuria despite treatment
• Continuously declining eGFR
• Uncertainty about kidney disease etiology

Common Pitfalls to Avoid

1. Don't delay referral for acute kidney injury: An abrupt sustained eGFR decrease >20% warrants nephrology consultation after excluding reversible causes 1

2. Don't rely solely on serum creatinine: It's insensitive for detecting CKD; always use eGFR 6, 7

3. Don't refer all patients with ACR >300 mg/g automatically: Consider the clinical context—patients with side effects to ACE inhibitors/ARBs or nephrotic-range proteinuria should be prioritized 2

4. Don't forget that most stage 3 CKD patients die from cardiovascular disease, not kidney failure: Primary care cardiovascular risk reduction is critical 1

Practical Algorithm

Step 1: Check eGFR

• If <30 → Refer to nephrology
• If 30-60 → Proceed to Step 2

Step 2: Assess albuminuria and other factors

• ACR ≥300 mg/g (or ≥600 mg/g per Canadian guidelines) → Refer
• Rapid progression (>20% eGFR decline) → Refer
• Resistant hypertension, hyperkalemia, unexplained hematuria → Refer

Step 3: Consider risk-based assessment

• Calculate 2-year KFRE
• If ≥10% → Refer

Step 4: For stable, isolated eGFR <30 in elderly patients with limited life expectancy, consider specialist advice rather than formal ongoing care 1